| 1 | [SID17512528] | Active | Potency | 2.6169 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Active | | Potency | 2.6169 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID17512528] | Active | Potency | 11.5821 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID17512528] | Active | Potency | 18.3564 | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. [AID624296, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. | | AID | 624296 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 4 | [SID17512528] | Active | AC50 | 29.773 | 24 hour HeLa Cytotox assay Measured in Cell-Based System Using Plate Reader - 2117-03_Inhibitor_Dose_CherryPick_Activity [AID504726, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Active | | AC50 | 29.773 [uM] | | BioAssay | 24 hour HeLa Cytotox assay Measured in Cell-Based System Using Plate Reader - 2117-03_Inhibitor_Dose_CherryPick_Activity | | AID | 504726 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 5 | [SID17512528] | Active | | | Screen for Chemicals that Inhibit the RAM Network [AID868, Type: screening] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Active | | BioAssay | Screen for Chemicals that Inhibit the RAM Network | | AID | 868 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID17512528] | Active | | | Leishmania major promastigote HTS [AID1063, Type: screening] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Active | | BioAssay | Leishmania major promastigote HTS | | AID | 1063 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID17512528] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID17512528] | Active | | | uHTS identification of HIF-2a Inhibitors in a luminesence assay [AID624352, Type: screening] | EPAS1 gene product [Homo sapiens] [gi:40254439] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Active | | BioAssay | uHTS identification of HIF-2a Inhibitors in a luminesence assay | | AID | 624352 | | BioAssay type | screening | | Target | EPAS1 gene product [Homo sapiens] [gi:40254439] | | PubMed | | | Data Table |  |
|
| 9 | [SID17512528] | Active | | | uHTS identification of HIF-2a Inhibitors in a luminesence assay [AID624352, Type: screening] | EPAS1 gene product [Homo sapiens] [gi:40254439] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Active | | BioAssay | uHTS identification of HIF-2a Inhibitors in a luminesence assay | | AID | 624352 | | BioAssay type | screening | | Target | EPAS1 gene product [Homo sapiens] [gi:40254439] | | PubMed | | | Data Table |  |
|
| 10 | [SID17512528] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels [AID2156, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels | | AID | 2156 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 11 | [SID17512528] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels [AID2156, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels | | AID | 2156 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 12 | [SID17512528] | Active | | | HTS Assay for Peg3 Promoter Inhibitors [AID588405, Type: screening] | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Active | | BioAssay | HTS Assay for Peg3 Promoter Inhibitors | | AID | 588405 | | BioAssay type | screening | | Target | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] | | PubMed | | | Data Table |  |
|
| 13 | [SID17512528] | Active | | | Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2 Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity [AID504523, Type: screening] | KEAP1 gene product [Homo sapiens] [gi:45269145] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Active | | BioAssay | Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2 Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504523 | | BioAssay type | screening | | Target | KEAP1 gene product [Homo sapiens] [gi:45269145] | | PubMed | | | Data Table |  |
|
| 14 | [SID17512528] | Active | | | Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2 Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity [AID504523, Type: screening] | KEAP1 gene product [Homo sapiens] [gi:45269145] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Active | | BioAssay | Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2 Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504523 | | BioAssay type | screening | | Target | KEAP1 gene product [Homo sapiens] [gi:45269145] | | PubMed | | | Data Table |  |
|
| 15 | [SID17512528] | Active | | | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID1974, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Active | | BioAssay | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 1974 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 16 | [SID17512528] | Active | | | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID1974, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Active | | BioAssay | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 1974 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 17 | [SID17512528] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID2176, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 2176 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 18 | [SID17512528] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID2176, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 2176 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 19 | [SID17512528] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 20 | [SID17512528] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 21 | [SID17512528] | Inactive | Potency | 11.2202 | qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy [AID624291, Type: confirmatory] | Glycoprotein hormones alpha chain [gi:121312] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy | | AID | 624291 | | BioAssay type | confirmatory | | Target | Glycoprotein hormones alpha chain [gi:121312] | | PubMed | | | Data Table |  |
|
| 22 | [SID17512528] | Inactive | Max_Activity_Concentration_uM | 12 | Thermal shift assay to identify compound binding to Kelch domain of Keap1 protein Measured in Biochemical System Using RT-PCR - 2119-02_Inhibitor_Dose_CherryPick_Activity [AID651823, Type: confirmatory] | KEAP1 gene product [Homo sapiens] [gi:45269145] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | Max_Activity_Concentration_uM | 12 [uM] | | BioAssay | Thermal shift assay to identify compound binding to Kelch domain of Keap1 protein Measured in Biochemical System Using RT-PCR - 2119-02_Inhibitor_Dose_CherryPick_Activity | | AID | 651823 | | BioAssay type | confirmatory | | Target | KEAP1 gene product [Homo sapiens] [gi:45269145] | | PubMed | | | Data Table |  |
|
| 23 | [SID17512528] | Inactive | Max_Activity_Concentration_uM | 12 | Thermal shift assay to identify compound binding to Kelch domain of Keap1 protein Measured in Biochemical System Using RT-PCR - 2119-02_Inhibitor_Dose_CherryPick_Activity [AID651823, Type: confirmatory] | KEAP1 gene product [Homo sapiens] [gi:45269145] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | Max_Activity_Concentration_uM | 12 [uM] | | BioAssay | Thermal shift assay to identify compound binding to Kelch domain of Keap1 protein Measured in Biochemical System Using RT-PCR - 2119-02_Inhibitor_Dose_CherryPick_Activity | | AID | 651823 | | BioAssay type | confirmatory | | Target | KEAP1 gene product [Homo sapiens] [gi:45269145] | | PubMed | | | Data Table |  |
|
| 24 | [SID17512528] | Inactive | Potency | 12.5893 | qHTS Assay for Inhibitors of the HIV-1 protein Vpr [AID651644, Type: confirmatory] | Vpr [Human immunodeficiency virus 1] [gi:28872817] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of the HIV-1 protein Vpr | | AID | 651644 | | BioAssay type | confirmatory | | Target | Vpr [Human immunodeficiency virus 1] [gi:28872817] | | PubMed | | | Data Table |  |
|
| 25 | [SID17512528] | Inactive | Potency | 22.3872 | qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression [AID624202, Type: confirmatory] | BRCA1 [Homo sapiens] [gi:1698399] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression | | AID | 624202 | | BioAssay type | confirmatory | | Target | BRCA1 [Homo sapiens] [gi:1698399] | | PubMed | | | Data Table |  |
|
| 26 | [SID17512528] | Inactive | Potency | 22.3872 | qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression [AID624202, Type: confirmatory] | BRCA1 [Homo sapiens] [gi:1698399] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression | | AID | 624202 | | BioAssay type | confirmatory | | Target | BRCA1 [Homo sapiens] [gi:1698399] | | PubMed | | | Data Table |  |
|
| 27 | [SID17512528] | Inactive | | | Primary cell-based high throughput screening assay to identify inhibitors of kruppel-like factor 5 (KLF5) [AID1700, Type: screening] | Kruppel-like factor 5 [Homo sapiens] [gi:124263658] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | BioAssay | Primary cell-based high throughput screening assay to identify inhibitors of kruppel-like factor 5 (KLF5) | | AID | 1700 | | BioAssay type | screening | | Target | Kruppel-like factor 5 [Homo sapiens] [gi:124263658] | | PubMed | | | Data Table |  |
|
| 28 | [SID17512528] | Inactive | | | Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3 [AID463141, Type: screening] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | BioAssay | Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3 | | AID | 463141 | | BioAssay type | screening | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 29 | [SID17512528] | Inactive | | | Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3 [AID463141, Type: screening] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | BioAssay | Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3 | | AID | 463141 | | BioAssay type | screening | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 30 | [SID17512528] | Inactive | | | Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3 [AID463141, Type: screening] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | BioAssay | Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3 | | AID | 463141 | | BioAssay type | screening | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 31 | [SID17512528] | Inactive | | | Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3 [AID463141, Type: screening] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | BioAssay | Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3 | | AID | 463141 | | BioAssay type | screening | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 32 | [SID17512528] | Inactive | IC50 | | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay. [AID1434, Type: confirmatory] | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay. | | AID | 1434 | | BioAssay type | confirmatory | | Target | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] | | PubMed | | | Data Table |  |
|
| 33 | [SID17512528] | Inactive | IC50 | | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay. [AID1434, Type: confirmatory] | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay. | | AID | 1434 | | BioAssay type | confirmatory | | Target | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] | | PubMed | | | Data Table |  |
|
| 34 | [SID17512528] | Inactive | | | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay. [AID1496, Type: screening] | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | BioAssay | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay. | | AID | 1496 | | BioAssay type | screening | | Target | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] | | PubMed | | | Data Table |  |
|
| 35 | [SID17512528] | Inactive | | | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay. [AID1496, Type: screening] | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | BioAssay | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay. | | AID | 1496 | | BioAssay type | screening | | Target | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] | | PubMed | | | Data Table |  |
|
| 36 | [SID17512528] | Inactive | | | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID588850, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | BioAssay | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 588850 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 37 | [SID17512528] | Inactive | | | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID588850, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | BioAssay | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 588850 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 38 | [SID17512528] | Inactive | | | Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity [AID504408, Type: screening] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | BioAssay | Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity | | AID | 504408 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID17512528] | Inactive | Potency | | Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity [AID504648, Type: confirmatory] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity | | AID | 504648 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID17512528] | Inactive | | | Counter Screen for Glucose-6-Phosphate Dehydrogenase-based Primary Assay [AID1020, Type: screening] | glucose-6-phosphate dehydrogenase [Leuconostoc mesenteroides] [gi:149631] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | BioAssay | Counter Screen for Glucose-6-Phosphate Dehydrogenase-based Primary Assay | | AID | 1020 | | BioAssay type | screening | | Target | glucose-6-phosphate dehydrogenase [Leuconostoc mesenteroides] [gi:149631] | | PubMed | | | Data Table |  |
|
| 41 | [SID17512528] | Inactive | Potency | | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) [AID588342, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) | | AID | 588342 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 42 | [SID17512528] | Inactive | | | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN. [AID2029, Type: screening] | citrate synthase 2 [Saccharomyces cerevisiae] [gi:171229] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | BioAssay | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN. | | AID | 2029 | | BioAssay type | screening | | Target | citrate synthase 2 [Saccharomyces cerevisiae] [gi:171229] | | PubMed | | | Data Table |  |
|
| 43 | [SID17512528] | Inactive | | | Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System [AID2094, Type: screening] | Chain A, Crystal Structure Of The Apo Form Of Vibrio Harveyi Luxp Complexed With The Periplasmic Dom [gi:67463988] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | BioAssay | Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System | | AID | 2094 | | BioAssay type | screening | | Target | Chain A, Crystal Structure Of The Apo Form Of Vibrio Harveyi Luxp Complexed With The Periplasmic Dom [gi:67463988] | | PubMed | | | Data Table |  |
|
| 44 | [SID17512528] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12) [AID652126, Type: screening] | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12) | | AID | 652126 | | BioAssay type | screening | | Target | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] | | PubMed | | | Data Table |  |
|
| 45 | [SID17512528] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12) [AID652067, Type: screening] | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12) | | AID | 652067 | | BioAssay type | screening | | Target | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] | | PubMed | | | Data Table |  |
|
| 46 | [SID17512528] | Inactive | | | QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro) [AID1706, Type: screening] | 3C-like protease [Infectious bronchitis virus] [gi:73745819] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | BioAssay | QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro) | | AID | 1706 | | BioAssay type | screening | | Target | 3C-like protease [Infectious bronchitis virus] [gi:73745819] | | PubMed | | | Data Table |  |
|
| 47 | [SID17512528] | Inactive | | | PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity [AID602405, Type: screening] | WlaI protein (PglD) [gi:75495260] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | BioAssay | PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602405 | | BioAssay type | screening | | Target | WlaI protein (PglD) [gi:75495260] | | PubMed | | | Data Table |  |
|
| 48 | [SID17512528] | Inactive | | | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate [AID651958, Type: screening] | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate | | AID | 651958 | | BioAssay type | screening | | Target | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] | | PubMed | | | Data Table |  |
|
| 49 | [SID17512528] | Inactive | | | TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization [AID1899, Type: screening] | core protein [Hepatitis C virus] [gi:83779224] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | BioAssay | TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization | | AID | 1899 | | BioAssay type | screening | | Target | core protein [Hepatitis C virus] [gi:83779224] | | PubMed | | | Data Table |  |
|
| 50 | [SID17512528] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 17512528 | | CID | 12005637 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|